$EYES Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in SECOND SIGHT MEDICAL PRODUCTS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in SECOND SIGHT MEDICAL PRODUCTS INC. Get notifications about new insider transactions in SECOND SIGHT MEDICAL PRODUCTS INC for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 12 2018 | EYES | SECOND SIGHT MEDIC ... | Williams Gregg | Director | Buy | P | 1.62 | 7,694 | 12,449 | 30,495,312 | 30.5 M to 30.5 M (+0.03 %) |
Oct 12 2018 | EYES | SECOND SIGHT MEDIC ... | Williams Gregg | Director | Buy | P | 1.60 | 11,709 | 18,746 | 30,487,618 | 30.5 M to 30.5 M (+0.04 %) |
Oct 12 2018 | EYES | SECOND SIGHT MEDIC ... | Williams Gregg | Director | Buy | P | 1.62 | 7,694 | 12,449 | 30,495,312 | 30.5 M to 30.5 M (+0.03 %) |
Oct 12 2018 | EYES | SECOND SIGHT MEDIC ... | Williams Gregg | Director | Buy | P | 1.60 | 11,709 | 18,746 | 30,487,618 | 30.5 M to 30.5 M (+0.04 %) |
Oct 10 2018 | EYES | SECOND SIGHT MEDIC ... | Williams Gregg | Director | Buy | P | 1.60 | 15,875 | 25,432 | 30,475,909 | 30.5 M to 30.5 M (+0.05 %) |
Oct 10 2018 | EYES | SECOND SIGHT MEDIC ... | Williams Gregg | Director | Buy | P | 1.64 | 10,458 | 17,182 | 30,460,034 | 30.4 M to 30.5 M (+0.03 %) |
Oct 09 2018 | EYES | SECOND SIGHT MEDIC ... | Williams Gregg | Director | Buy | P | 1.72 | 15,875 | 27,305 | 30,449,576 | 30.4 M to 30.4 M (+0.05 %) |
Oct 09 2018 | EYES | SECOND SIGHT MEDIC ... | Williams Gregg | Director | Buy | P | 1.79 | 10,894 | 19,446 | 30,433,701 | 30.4 M to 30.4 M (+0.04 %) |
Oct 04 2018 | EYES | SECOND SIGHT MEDIC ... | Williams Gregg | Director | Buy | P | 1.76 | 8,200 | 14,391 | 30,422,807 | 30.4 M to 30.4 M (+0.03 %) |
Oct 04 2018 | EYES | SECOND SIGHT MEDIC ... | Williams Gregg | Director | Buy | P | 1.81 | 15,875 | 28,750 | 30,414,607 | 30.4 M to 30.4 M (+0.05 %) |
Oct 02 2018 | EYES | SECOND SIGHT MEDIC ... | McGuire Jonathan Will | Chief Executive Off ... | Buy | S | 1.87 | 10,000 | 18,660 | 95,798 | 85.8 K to 95.8 K (+11.66 %) |
Oct 01 2018 | EYES | SECOND SIGHT MEDIC ... | Williams Gregg | Director | Buy | P | 1.86 | 15,875 | 29,543 | 30,398,732 | 30.4 M to 30.4 M (+0.05 %) |
Oct 01 2018 | EYES | SECOND SIGHT MEDIC ... | Williams Gregg | Director | Buy | P | 1.90 | 9,223 | 17,542 | 30,382,857 | 30.4 M to 30.4 M (+0.03 %) |
Sep 27 2018 | EYES | SECOND SIGHT MEDIC ... | Williams Gregg | Director | Buy | P | 1.93 | 15,875 | 30,702 | 30,373,634 | 30.4 M to 30.4 M (+0.05 %) |
Sep 27 2018 | EYES | SECOND SIGHT MEDIC ... | Williams Gregg | Director | Buy | P | 1.96 | 10,878 | 21,288 | 30,357,759 | 30.3 M to 30.4 M (+0.04 %) |
Sep 25 2018 | EYES | SECOND SIGHT MEDIC ... | Williams Gregg | Director | Buy | P | 1.89 | 15,875 | 29,924 | 30,346,881 | 30.3 M to 30.3 M (+0.05 %) |
Sep 25 2018 | EYES | SECOND SIGHT MEDIC ... | Williams Gregg | Director | Buy | P | 1.86 | 15,520 | 28,883 | 30,331,006 | 30.3 M to 30.3 M (+0.05 %) |
Sep 21 2018 | EYES | SECOND SIGHT MEDIC ... | Williams Gregg | Director | Buy | P | 1.80 | 15,875 | 28,496 | 30,315,486 | 30.3 M to 30.3 M (+0.05 %) |
Sep 21 2018 | EYES | SECOND SIGHT MEDIC ... | Williams Gregg | Director | Buy | P | 1.82 | 15,875 | 28,908 | 30,299,611 | 30.3 M to 30.3 M (+0.05 %) |
Sep 19 2018 | EYES | SECOND SIGHT MEDIC ... | Williams Gregg | Director | Buy | P | 1.76 | 13,741 | 24,170 | 30,283,736 | 30.3 M to 30.3 M (+0.05 %) |
Sep 19 2018 | EYES | SECOND SIGHT MEDIC ... | Williams Gregg | Director | Buy | P | 1.87 | 15,875 | 29,734 | 30,269,995 | 30.3 M to 30.3 M (+0.05 %) |
Sep 17 2018 | EYES | SECOND SIGHT MEDIC ... | Williams Gregg | Director | Buy | P | 1.79 | 15,875 | 28,416 | 30,254,120 | 30.2 M to 30.3 M (+0.05 %) |
Sep 17 2018 | EYES | SECOND SIGHT MEDIC ... | Williams Gregg | Director | Buy | P | 1.69 | 10,200 | 17,218 | 30,238,245 | 30.2 M to 30.2 M (+0.03 %) |
Sep 17 2018 | EYES | SECOND SIGHT MEDIC ... | Williams Gregg | Director | Buy | P | 1.79 | 15,875 | 28,416 | 30,254,120 | 30.2 M to 30.3 M (+0.05 %) |
Sep 17 2018 | EYES | SECOND SIGHT MEDIC ... | Williams Gregg | Director | Buy | P | 1.69 | 10,200 | 17,218 | 30,238,245 | 30.2 M to 30.2 M (+0.03 %) |
Sep 13 2018 | EYES | SECOND SIGHT MEDIC ... | Williams Gregg | Director | Buy | P | 1.67 | 15,875 | 26,543 | 30,228,045 | 30.2 M to 30.2 M (+0.05 %) |
Sep 13 2018 | EYES | SECOND SIGHT MEDIC ... | Williams Gregg | Director | Buy | P | 1.62 | 15,875 | 25,765 | 30,212,170 | 30.2 M to 30.2 M (+0.05 %) |
Sep 12 2018 | EYES | SECOND SIGHT MEDIC ... | Williams Gregg | Director | Buy | P | 1.68 | 15,875 | 26,622 | 30,196,295 | 30.2 M to 30.2 M (+0.05 %) |
Sep 12 2018 | EYES | SECOND SIGHT MEDIC ... | Williams Gregg | Director | Buy | P | 1.69 | 10,608 | 17,917 | 30,180,420 | 30.2 M to 30.2 M (+0.04 %) |
Sep 10 2018 | EYES | SECOND SIGHT MEDIC ... | Williams Gregg | Director | Buy | P | 1.73 | 15,875 | 27,448 | 30,169,812 | 30.2 M to 30.2 M (+0.05 %) |
Sep 10 2018 | EYES | SECOND SIGHT MEDIC ... | Williams Gregg | Director | Buy | P | 1.76 | 15,875 | 27,924 | 30,153,937 | 30.1 M to 30.2 M (+0.05 %) |
Sep 06 2018 | EYES | SECOND SIGHT MEDIC ... | McGuire Jonathan Will | Chief Executive Off ... | Buy | S | 1.68 | 10,000 | 16,750 | 105,798 | 95.8 K to 105.8 K (+10.44 %) |
Sep 05 2018 | EYES | SECOND SIGHT MEDIC ... | Williams Gregg | Director | Buy | P | 1.70 | 14,953 | 25,405 | 30,138,062 | 30.1 M to 30.1 M (+0.05 %) |
Sep 05 2018 | EYES | SECOND SIGHT MEDIC ... | Williams Gregg | Director | Buy | P | 1.68 | 15,875 | 26,638 | 30,123,109 | 30.1 M to 30.1 M (+0.05 %) |
Aug 31 2018 | EYES | SECOND SIGHT MEDIC ... | Williams Gregg | Director | Buy | P | 1.73 | 15,875 | 27,480 | 30,107,234 | 30.1 M to 30.1 M (+0.05 %) |
Aug 31 2018 | EYES | SECOND SIGHT MEDIC ... | Williams Gregg | Director | Buy | P | 1.71 | 15,875 | 27,194 | 30,091,359 | 30.1 M to 30.1 M (+0.05 %) |
Aug 29 2018 | EYES | SECOND SIGHT MEDIC ... | Williams Gregg | Director | Buy | P | 1.61 | 15,720 | 25,372 | 30,075,484 | 30.1 M to 30.1 M (+0.05 %) |
Aug 29 2018 | EYES | SECOND SIGHT MEDIC ... | Williams Gregg | Director | Buy | P | 1.59 | 14,140 | 22,426 | 30,059,764 | 30 M to 30.1 M (+0.05 %) |
Aug 29 2018 | EYES | SECOND SIGHT MEDIC ... | Williams Gregg | Director | Buy | P | 1.61 | 15,720 | 25,372 | 30,075,484 | 30.1 M to 30.1 M (+0.05 %) |
Aug 29 2018 | EYES | SECOND SIGHT MEDIC ... | Williams Gregg | Director | Buy | P | 1.59 | 14,140 | 22,426 | 30,059,764 | 30 M to 30.1 M (+0.05 %) |
Aug 27 2018 | EYES | SECOND SIGHT MEDIC ... | Williams Gregg | Director | Buy | P | 1.57 | 10,623 | 16,721 | 30,045,624 | 30 M to 30 M (+0.04 %) |
Aug 27 2018 | EYES | SECOND SIGHT MEDIC ... | Williams Gregg | Director | Buy | P | 1.59 | 12,700 | 20,244 | 30,035,001 | 30 M to 30 M (+0.04 %) |
Aug 27 2018 | EYES | SECOND SIGHT MEDIC ... | Williams Gregg | Director | Buy | P | 1.57 | 10,623 | 16,721 | 30,045,624 | 30 M to 30 M (+0.04 %) |
Aug 27 2018 | EYES | SECOND SIGHT MEDIC ... | Williams Gregg | Director | Buy | P | 1.59 | 12,700 | 20,244 | 30,035,001 | 30 M to 30 M (+0.04 %) |
Aug 23 2018 | EYES | SECOND SIGHT MEDIC ... | Williams Gregg | Director | Buy | P | 1.62 | 5,983 | 9,704 | 30,022,301 | 30 M to 30 M (+0.02 %) |
Aug 23 2018 | EYES | SECOND SIGHT MEDIC ... | Williams Gregg | Director | Buy | P | 1.63 | 11,069 | 18,087 | 30,016,318 | 30 M to 30 M (+0.04 %) |
Aug 22 2018 | EYES | SECOND SIGHT MEDIC ... | McGuire Jonathan Will | Chief Executive Off ... | Option Exercise | M | 0.00 | 11,875 | 0 | 47,500 | |
Aug 22 2018 | EYES | SECOND SIGHT MEDIC ... | McGuire Jonathan Will | Chief Executive Off ... | Buy | S | 1.60 | 3,777 | 6,043 | 115,798 | 112 K to 115.8 K (+3.37 %) |
Aug 22 2018 | EYES | SECOND SIGHT MEDIC ... | McGuire Jonathan Will | Chief Executive Off ... | Buy | M | 0.00 | 11,875 | 0 | 119,575 | 107.7 K to 119.6 K (+11.03 %) |
Aug 21 2018 | EYES | SECOND SIGHT MEDIC ... | Williams Gregg | Director | Buy | P | 1.63 | 15,875 | 25,845 | 30,005,249 | 30 M to 30 M (+0.05 %) |
Aug 21 2018 | EYES | SECOND SIGHT MEDIC ... | Williams Gregg | Director | Buy | P | 1.57 | 4,110 | 6,469 | 29,989,374 | 30 M to 30 M (+0.01 %) |
Aug 17 2018 | EYES | SECOND SIGHT MEDIC ... | Williams Gregg | Director | Buy | P | 1.56 | 7,800 | 12,137 | 29,985,264 | 30 M to 30 M (+0.03 %) |
Aug 17 2018 | EYES | SECOND SIGHT MEDIC ... | Williams Gregg | Director | Buy | P | 1.56 | 10,263 | 16,010 | 29,977,464 | 30 M to 30 M (+0.03 %) |
Aug 16 2018 | EYES | SECOND SIGHT MEDIC ... | Williams Gregg | Director | Buy | P | 1.53 | 15,875 | 24,289 | 29,967,201 | 30 M to 30 M (+0.05 %) |
Aug 16 2018 | EYES | SECOND SIGHT MEDIC ... | Williams Gregg | Director | Buy | P | 1.55 | 3,225,807 | 5,000,001 | 29,951,326 | 26.7 M to 30 M (+12.07 %) |
Aug 16 2018 | EYES | SECOND SIGHT MEDIC ... | Williams Gregg | Director | Buy | P | 1.56 | 5,680 | 8,866 | 26,725,519 | 26.7 M to 26.7 M (+0.02 %) |
Aug 13 2018 | EYES | SECOND SIGHT MEDIC ... | Williams Gregg | Director | Buy | P | 1.60 | 7,000 | 11,165 | 26,719,839 | 26.7 M to 26.7 M (+0.03 %) |
Aug 13 2018 | EYES | SECOND SIGHT MEDIC ... | Williams Gregg | Director | Buy | P | 1.60 | 7,000 | 11,165 | 26,719,839 | 26.7 M to 26.7 M (+0.03 %) |
Aug 13 2018 | EYES | SECOND SIGHT MEDIC ... | Williams Gregg | Director | Buy | P | 1.55 | 15,875 | 24,622 | 26,712,839 | 26.7 M to 26.7 M (+0.06 %) |
Aug 13 2018 | EYES | SECOND SIGHT MEDIC ... | Williams Gregg | Director | Buy | P | 1.55 | 15,875 | 24,622 | 26,712,839 | 26.7 M to 26.7 M (+0.06 %) |
Aug 09 2018 | EYES | SECOND SIGHT MEDIC ... | Williams Gregg | Director | Buy | P | 1.54 | 6,634 | 10,243 | 26,696,964 | 26.7 M to 26.7 M (+0.02 %) |
Aug 09 2018 | EYES | SECOND SIGHT MEDIC ... | Williams Gregg | Director | Buy | P | 1.58 | 15,875 | 25,114 | 26,690,330 | 26.7 M to 26.7 M (+0.06 %) |
Aug 07 2018 | EYES | SECOND SIGHT MEDIC ... | Williams Gregg | Director | Buy | P | 1.67 | 7,960 | 13,325 | 26,674,455 | 26.7 M to 26.7 M (+0.03 %) |
Aug 07 2018 | EYES | SECOND SIGHT MEDIC ... | Williams Gregg | Director | Buy | P | 1.66 | 8,188 | 13,568 | 26,666,495 | 26.7 M to 26.7 M (+0.03 %) |
Jul 30 2018 | EYES | SECOND SIGHT MEDIC ... | Williams Gregg | Director | Buy | P | 1.60 | 15,875 | 25,432 | 26,658,307 | 26.6 M to 26.7 M (+0.06 %) |
Jul 30 2018 | EYES | SECOND SIGHT MEDIC ... | Williams Gregg | Director | Buy | P | 1.65 | 7,874 | 13,016 | 26,642,432 | 26.6 M to 26.6 M (+0.03 %) |
Jul 25 2018 | EYES | SECOND SIGHT MEDIC ... | Williams Gregg | Director | Buy | P | 1.60 | 10,402 | 16,685 | 26,635,638 | 26.6 M to 26.6 M (+0.04 %) |
Jul 25 2018 | EYES | SECOND SIGHT MEDIC ... | Williams Gregg | Director | Buy | P | 1.62 | 15,875 | 25,718 | 26,625,236 | 26.6 M to 26.6 M (+0.06 %) |
Jul 24 2018 | EYES | SECOND SIGHT MEDIC ... | Williams Gregg | Director | Buy | P | 1.67 | 15,875 | 26,448 | 26,609,361 | 26.6 M to 26.6 M (+0.06 %) |
Jul 24 2018 | EYES | SECOND SIGHT MEDIC ... | Williams Gregg | Director | Buy | P | 1.67 | 8,601 | 14,389 | 26,593,486 | 26.6 M to 26.6 M (+0.03 %) |
Jul 19 2018 | EYES | SECOND SIGHT MEDIC ... | Williams Gregg | Director | Buy | P | 1.69 | 6,885 | 11,663 | 26,584,885 | 26.6 M to 26.6 M (+0.03 %) |
Jul 19 2018 | EYES | SECOND SIGHT MEDIC ... | Williams Gregg | Director | Buy | P | 1.72 | 15,875 | 27,353 | 26,578,000 | 26.6 M to 26.6 M (+0.06 %) |
Jul 18 2018 | EYES | SECOND SIGHT MEDIC ... | Williams Gregg | Director | Buy | P | 1.80 | 15,875 | 28,512 | 26,562,125 | 26.5 M to 26.6 M (+0.06 %) |
Jul 18 2018 | EYES | SECOND SIGHT MEDIC ... | Williams Gregg | Director | Buy | P | 1.77 | 9,700 | 17,121 | 26,546,250 | 26.5 M to 26.5 M (+0.04 %) |
Jun 18 2018 | EYES | SECOND SIGHT MEDIC ... | Williams Gregg | Director | Buy | P | 1.80 | 9,327 | 16,798 | 26,536,550 | 26.5 M to 26.5 M (+0.04 %) |
Jun 14 2018 | EYES | SECOND SIGHT MEDIC ... | Williams Gregg | Director | Buy | P | 1.82 | 24,498 | 44,464 | 26,527,223 | 26.5 M to 26.5 M (+0.09 %) |
Jun 14 2018 | EYES | SECOND SIGHT MEDIC ... | Williams Gregg | Director | Buy | P | 1.86 | 10,737 | 19,939 | 26,502,725 | 26.5 M to 26.5 M (+0.04 %) |
Jun 12 2018 | EYES | SECOND SIGHT MEDIC ... | Williams Gregg | Director | Buy | P | 1.83 | 21,737 | 39,822 | 26,491,988 | 26.5 M to 26.5 M (+0.08 %) |
Jun 12 2018 | EYES | SECOND SIGHT MEDIC ... | Williams Gregg | Director | Buy | P | 1.84 | 26,922 | 49,510 | 26,470,251 | 26.4 M to 26.5 M (+0.10 %) |
Jun 08 2018 | EYES | SECOND SIGHT MEDIC ... | Williams Gregg | Director | Buy | P | 1.80 | 16,954 | 30,483 | 26,443,329 | 26.4 M to 26.4 M (+0.06 %) |
Jun 08 2018 | EYES | SECOND SIGHT MEDIC ... | Williams Gregg | Director | Buy | P | 1.86 | 29,908 | 55,569 | 26,426,375 | 26.4 M to 26.4 M (+0.11 %) |
Jun 06 2018 | EYES | SECOND SIGHT MEDIC ... | Williams Gregg | Director | Buy | P | 1.90 | 22,165 | 42,180 | 26,396,467 | 26.4 M to 26.4 M (+0.08 %) |
Jun 06 2018 | EYES | SECOND SIGHT MEDIC ... | Williams Gregg | Director | Buy | P | 1.94 | 21,678 | 41,947 | 26,374,302 | 26.4 M to 26.4 M (+0.08 %) |
Jun 05 2018 | EYES | SECOND SIGHT MEDIC ... | PFEFFER MATTHEW J | Director | Option Exercise | A | 2.05 | 25,970 | 53,239 | 25,970 | |
Jun 05 2018 | EYES | SECOND SIGHT MEDIC ... | PFEFFER MATTHEW J | Director | Grant | A | 0.00 | 35,533 | 0 | 118,301 | 82.8 K to 118.3 K (+42.93 %) |
Jun 05 2018 | EYES | SECOND SIGHT MEDIC ... | PFEFFER MATTHEW J | Director | Option Exercise | A | 2.05 | 25,970 | 53,239 | 25,970 | |
Jun 05 2018 | EYES | SECOND SIGHT MEDIC ... | Williams Gregg | Director | Option Exercise | A | 2.05 | 25,970 | 53,239 | 25,970 | |
Jun 05 2018 | EYES | SECOND SIGHT MEDIC ... | PFEFFER MATTHEW J | Director | Grant | A | 0.00 | 35,533 | 0 | 118,301 | 82.8 K to 118.3 K (+42.93 %) |
Jun 05 2018 | EYES | SECOND SIGHT MEDIC ... | Williams Gregg | Director | Grant | A | 0.00 | 33,503 | 0 | 26,352,624 | 26.3 M to 26.4 M (+0.13 %) |
Jun 05 2018 | EYES | SECOND SIGHT MEDIC ... | Williams Gregg | Director | Buy | P | 1.95 | 26,485 | 51,513 | 26,319,121 | 26.3 M to 26.3 M (+0.10 %) |
Jun 05 2018 | EYES | SECOND SIGHT MEDIC ... | Williams Gregg | Director | Option Exercise | A | 2.05 | 25,970 | 53,239 | 25,970 | |
Jun 05 2018 | EYES | SECOND SIGHT MEDIC ... | Mendelsohn Aaron | Director | Option Exercise | A | 2.05 | 25,970 | 53,239 | 25,970 | |
Jun 05 2018 | EYES | SECOND SIGHT MEDIC ... | Williams Gregg | Director | Grant | A | 0.00 | 33,503 | 0 | 26,352,624 | 26.3 M to 26.4 M (+0.13 %) |
Jun 05 2018 | EYES | SECOND SIGHT MEDIC ... | Mendelsohn Aaron | Director | Grant | A | 0.00 | 29,442 | 0 | 133,807 | 104.4 K to 133.8 K (+28.21 %) |
Jun 05 2018 | EYES | SECOND SIGHT MEDIC ... | Williams Gregg | Director | Buy | P | 1.95 | 26,485 | 51,513 | 26,319,121 | 26.3 M to 26.3 M (+0.10 %) |
Jun 05 2018 | EYES | SECOND SIGHT MEDIC ... | LINK WILLIAM J PHD | Director | Option Exercise | A | 2.05 | 25,970 | 53,239 | 25,970 | |
Jun 05 2018 | EYES | SECOND SIGHT MEDIC ... | LINK WILLIAM J PHD | Director | Grant | A | 0.00 | 34,518 | 0 | 115,186 | 80.7 K to 115.2 K (+42.79 %) |
Jun 05 2018 | EYES | SECOND SIGHT MEDIC ... | Mendelsohn Aaron | Director | Option Exercise | A | 2.05 | 25,970 | 53,239 | 25,970 | |
Jun 05 2018 | EYES | SECOND SIGHT MEDIC ... | Mendelsohn Aaron | Director | Grant | A | 0.00 | 29,442 | 0 | 133,807 | 104.4 K to 133.8 K (+28.21 %) |
Jun 05 2018 | EYES | SECOND SIGHT MEDIC ... | LINK WILLIAM J PHD | Director | Option Exercise | A | 2.05 | 25,970 | 53,239 | 25,970 | |
Jun 05 2018 | EYES | SECOND SIGHT MEDIC ... | LINK WILLIAM J PHD | Director | Grant | A | 0.00 | 34,518 | 0 | 115,186 | 80.7 K to 115.2 K (+42.79 %) |
Jun 01 2018 | EYES | SECOND SIGHT MEDIC ... | Williams Gregg | Director | Buy | P | 1.99 | 25,355 | 50,330 | 26,292,636 | 26.3 M to 26.3 M (+0.10 %) |
Jun 01 2018 | EYES | SECOND SIGHT MEDIC ... | OKLAND STEPHEN D | Chief Commercial Of ... | Sell | S | 1.96 | 7,435 | 14,587 | 23,641 | 31.1 K to 23.6 K (-23.93 %) |
Jun 01 2018 | EYES | SECOND SIGHT MEDIC ... | OKLAND STEPHEN D | Chief Commercial Of ... | Grant | A | 1.16 | 7,435 | 8,595 | 31,076 | 23.6 K to 31.1 K (+31.45 %) |
Jun 01 2018 | EYES | SECOND SIGHT MEDIC ... | McGuire Jonathan Will | Chief Executive Off ... | Grant | A | 1.16 | 10,582 | 12,233 | 107,700 | 97.1 K to 107.7 K (+10.90 %) |
Jun 01 2018 | EYES | SECOND SIGHT MEDIC ... | Randolph Edward David | Vice President - Ma ... | Sell | S | 1.96 | 16,023 | 31,437 | 22 | 16 K to 22 (-99.86 %) |
Jun 01 2018 | EYES | SECOND SIGHT MEDIC ... | Randolph Edward David | Vice President - Ma ... | Grant | A | 1.16 | 16,023 | 18,523 | 16,045 | 22 to 16 K (+72,831.82 %) |
May 31 2018 | EYES | SECOND SIGHT MEDIC ... | Williams Gregg | Director | Buy | P | 1.98 | 15,602 | 30,892 | 26,267,281 | 26.3 M to 26.3 M (+0.06 %) |
May 31 2018 | EYES | SECOND SIGHT MEDIC ... | Williams Gregg | Director | Buy | P | 1.98 | 15,602 | 30,892 | 26,267,281 | 26.3 M to 26.3 M (+0.06 %) |
May 30 2018 | EYES | SECOND SIGHT MEDIC ... | Williams Gregg | Director | Buy | P | 1.98 | 12,350 | 24,404 | 26,251,679 | 26.2 M to 26.3 M (+0.05 %) |
May 30 2018 | EYES | SECOND SIGHT MEDIC ... | Williams Gregg | Director | Buy | P | 1.98 | 12,350 | 24,404 | 26,251,679 | 26.2 M to 26.3 M (+0.05 %) |
May 22 2018 | EYES | SECOND SIGHT MEDIC ... | McGuire Jonathan Will | Chief Executive Off ... | Option Exercise | M | 0.00 | 11,875 | 0 | 59,375 | |
May 22 2018 | EYES | SECOND SIGHT MEDIC ... | McGuire Jonathan Will | Chief Executive Off ... | Sell | S | 2.18 | 3,755 | 8,186 | 97,118 | 100.9 K to 97.1 K (-3.72 %) |
May 22 2018 | EYES | SECOND SIGHT MEDIC ... | McGuire Jonathan Will | Chief Executive Off ... | Buy | M | 0.00 | 11,875 | 0 | 100,873 | 89 K to 100.9 K (+13.34 %) |
May 18 2018 | EYES | SECOND SIGHT MEDIC ... | OKLAND STEPHEN D | Commercial V.P, Nor ... | Option Exercise | A | 2.05 | 50,000 | 102,500 | 50,000 | |
May 07 2018 | EYES | SECOND SIGHT MEDIC ... | Williams Gregg | Director | Buy | P | 1.48 | 2,027,027 | 3,000,000 | 26,239,329 | 24.2 M to 26.2 M (+8.37 %) |
May 07 2018 | EYES | SECOND SIGHT MEDIC ... | Williams Gregg | Director | Buy | P | 1.48 | 4,729,730 | 7,000,000 | 24,212,302 | 19.5 M to 24.2 M (+24.28 %) |
May 07 2018 | EYES | SECOND SIGHT MEDIC ... | Williams Gregg | Director | Buy | P | 1.48 | 2,027,027 | 3,000,000 | 26,239,329 | 24.2 M to 26.2 M (+8.37 %) |
May 07 2018 | EYES | SECOND SIGHT MEDIC ... | Williams Gregg | Director | Buy | P | 1.48 | 4,729,730 | 7,000,000 | 24,212,302 | 19.5 M to 24.2 M (+24.28 %) |
Mar 12 2018 | EYES | SECOND SIGHT MEDIC ... | McGuire Jonathan Will | Chief Executive Off ... | Option Exercise | M | 0.00 | 11,875 | 0 | 71,250 | |
Mar 12 2018 | EYES | SECOND SIGHT MEDIC ... | McGuire Jonathan Will | Chief Executive Off ... | Sell | D | 1.69 | 4,216 | 7,125 | 88,998 | 93.2 K to 89 K (-4.52 %) |
Mar 12 2018 | EYES | SECOND SIGHT MEDIC ... | McGuire Jonathan Will | Chief Executive Off ... | Buy | M | 1.73 | 11,875 | 20,544 | 93,214 | 81.3 K to 93.2 K (+14.60 %) |
Jan 23 2018 | EYES | SECOND SIGHT MEDIC ... | MILLER THOMAS B | Chief Financial Off ... | Option Exercise | A | 1.83 | 150,000 | 274,500 | 150,000 | |
Jan 08 2018 | EYES | SECOND SIGHT MEDIC ... | Jacques David Murray | VP-Research Develop ... | Option Exercise | A | 2.06 | 125,000 | 257,500 | 125,000 | |
Jan 08 2018 | EYES | SECOND SIGHT MEDIC ... | Randolph Edward David | Vice President of M ... | Option Exercise | A | 2.06 | 45,000 | 92,700 | 45,000 | |
Jan 08 2018 | EYES | SECOND SIGHT MEDIC ... | Greenberg Robert J. | Chairman of Board | Option Exercise | A | 2.06 | 140,000 | 288,400 | 140,000 | |
Jan 08 2018 | EYES | SECOND SIGHT MEDIC ... | McGuire Jonathan Will | Chief Executive Off ... | Option Exercise | A | 2.06 | 450,000 | 927,000 | 450,000 | |
Jan 08 2018 | EYES | SECOND SIGHT MEDIC ... | Cosendai Gregoire | VP Clinical Affairs | Option Exercise | A | 2.06 | 65,000 | 133,900 | 65,000 | |
Jan 08 2018 | EYES | SECOND SIGHT MEDIC ... | OKLAND STEPHEN D | Commercial VP, Nort ... | Option Exercise | A | 2.06 | 140,000 | 288,400 | 140,000 | |
Dec 04 2017 | EYES | SECOND SIGHT MEDIC ... | Randolph Edward David | Vice President of M ... | Grant | A | 1.25 | 18,553 | 23,191 | 22 | 18.6 K to 22 (-99.88 %) |
Dec 04 2017 | EYES | SECOND SIGHT MEDIC ... | Randolph Edward David | Vice President of M ... | Grant | A | 0.96 | 18,553 | 17,811 | 18,575 | 22 to 18.6 K (+84,331.82 %) |
Nov 24 2017 | EYES | SECOND SIGHT MEDIC ... | Williams Gregg | Director | Buy | P | 1.19 | 24,604 | 29,234 | 19,482,572 | 19.5 M to 19.5 M (+0.13 %) |
Nov 22 2017 | EYES | SECOND SIGHT MEDIC ... | McGuire Jonathan Will | Chief Executive Off ... | Option Exercise | M | 0.00 | 11,875 | 0 | 83,125 | |
Nov 22 2017 | EYES | SECOND SIGHT MEDIC ... | McGuire Jonathan Will | Chief Executive Off ... | Sell | D | 1.18 | 4,522 | 5,336 | 81,339 | 85.9 K to 81.3 K (-5.27 %) |
Nov 22 2017 | EYES | SECOND SIGHT MEDIC ... | McGuire Jonathan Will | Chief Executive Off ... | Buy | M | 1.19 | 11,875 | 14,131 | 85,861 | 74 K to 85.9 K (+16.05 %) |
Nov 21 2017 | EYES | SECOND SIGHT MEDIC ... | Williams Gregg | Director | Buy | P | 1.18 | 11,600 | 13,727 | 19,457,968 | 19.4 M to 19.5 M (+0.06 %) |
Nov 21 2017 | EYES | SECOND SIGHT MEDIC ... | Williams Gregg | Director | Buy | P | 1.17 | 5,420 | 6,338 | 19,446,368 | 19.4 M to 19.4 M (+0.03 %) |
Aug 31 2017 | EYES | SECOND SIGHT MEDIC ... | McGuire Jonathan Will | Chief Executive Off ... | Option Exercise | M | 0.00 | 11,875 | 0 | 95,000 | |
Aug 31 2017 | EYES | SECOND SIGHT MEDIC ... | McGuire Jonathan Will | Chief Executive Off ... | Sell | D | 1.08 | 4,921 | 5,315 | 73,986 | 78.9 K to 74 K (-6.24 %) |
Aug 31 2017 | EYES | SECOND SIGHT MEDIC ... | McGuire Jonathan Will | Chief Executive Off ... | Buy | M | 0.97 | 11,875 | 11,519 | 78,907 | 67 K to 78.9 K (+17.72 %) |
Jun 07 2017 | EYES | SECOND SIGHT MEDIC ... | Greenberg Robert J. | Chairman of Board | Grant | A | 1.13 | 13,090 | 14,792 | 172,911 | 186 K to 172.9 K (-7.04 %) |
Jun 07 2017 | EYES | SECOND SIGHT MEDIC ... | Greenberg Robert J. | Chairman of Board | Grant | A | 0.98 | 13,090 | 12,802 | 186,001 | 172.9 K to 186 K (+7.57 %) |
Jun 05 2017 | EYES | SECOND SIGHT MEDIC ... | PFEFFER MATTHEW J | Director | Grant | A | 1.17 | 59,725 | 69,998 | 82,768 | 23 K to 82.8 K (+259.19 %) |
Jun 05 2017 | EYES | SECOND SIGHT MEDIC ... | Mendelsohn Aaron | Director | Grant | A | 1.17 | 49,488 | 58,000 | 104,365 | 54.9 K to 104.4 K (+90.18 %) |
Jun 05 2017 | EYES | SECOND SIGHT MEDIC ... | LINK WILLIAM J PHD | Director | Grant | A | 1.17 | 58,021 | 68,001 | 80,668 | 22.6 K to 80.7 K (+256.20 %) |
Jun 05 2017 | EYES | SECOND SIGHT MEDIC ... | Williams Gregg | Director | Grant | A | 1.17 | 56,314 | 66,000 | 19,440,948 | 19.4 M to 19.4 M (+0.29 %) |
May 23 2017 | EYES | SECOND SIGHT MEDIC ... | MILLER THOMAS B | Chief Financial Off ... | Option Exercise | P | 1.47 | 5,500 | 8,085 | 86,135 | |
May 23 2017 | EYES | SECOND SIGHT MEDIC ... | MILLER THOMAS B | Chief Financial Off ... | Option Exercise | P | 1.47 | 5,000 | 7,350 | 80,635 | |
May 23 2017 | EYES | SECOND SIGHT MEDIC ... | MILLER THOMAS B | Chief Financial Off ... | Option Exercise | P | 1.47 | 5,200 | 7,644 | 75,635 | |
May 23 2017 | EYES | SECOND SIGHT MEDIC ... | MILLER THOMAS B | Chief Financial Off ... | Option Exercise | P | 1.47 | 3,000 | 4,410 | 70,435 |